Patents
Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
08/2006
08/30/2006EP1694638A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
08/30/2006EP1089982B1 Methods of inhibiting corrosion using isomers of chloro-methylbenzotriazole
08/30/2006CN1826310A Novel aminobenzophenone compounds
08/29/2006US7098343 Polycyclic compounds containing a central trivalent atom to which is attached either direct or indirectly via a linker a two or three ring system and a ring system contining sulphamate group as substituent; steroid sulfatase inhibitor
08/29/2006CA2395050C N-(5,7-dimethoxy[1,2,4]triazolo[1,5-a]pyrimidin-2-yl) arylsulfonamide compounds and their use as herbicides
08/24/2006WO2006087077A2 Hsp90-inhibiting triazole derivatives
08/24/2006WO2006065726A3 Process for preparing voriconazole
08/24/2006WO2005004810A3 Arylsulfonamide derivatives
08/24/2006US20060189671 Compounds, compositions, and methods
08/24/2006US20060189670 Process for the preparation of anastrozole and intermediates thereof
08/24/2006US20060189549 Chalcone derivatives and their use to treat diseases
08/24/2006DE102005007304A1 Triazolderivate Triazole derivatives
08/24/2006CA2598017A1 Triazole derivatives
08/23/2006EP1693358A1 Process for producing epoxytriazole compound and intermediate therefor
08/23/2006EP1692502A2 Use of the lipoxin receptor, fprl1, as a tool for identifying compounds effective in the treatment of pain and inflammation
08/23/2006EP1692116A1 1,2,3-triazole amide derivatives as inhibitors of cytokine production
08/23/2006EP1692110A1 Diacylhydrazine derivatives
08/23/2006CN1823068A Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
08/23/2006CN1821232A Rectifying method for methyl benzotrizole
08/23/2006CN1271071C Substituted (6-2-tolyl)-triazolopyrimidines as fungicides
08/22/2006US7094904 Process for preparing monohydrate and crystal modifications of fluconazole
08/22/2006US7094902 Electroactive polymers
08/22/2006US7094872 Activated polyethylene glycol esters
08/22/2006US7094801 Inhibiting the expression of VCAM-1; treating inflammatory disorders including rheumatoid arthritis, atherosclerosis, COPD, asthma, allergic rhinitis and restinosis
08/17/2006WO2006086705A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
08/17/2006WO2006085510A1 Remedy for irritable bowel syndrome
08/17/2006WO2005115383A3 Substituted triazoles as modulators of ppar and methods of their preparation
08/17/2006DE102005000904A1 New 1,3,5-Triarylated 1,2,4-triazole derivatives useful in organic electroluminescent device
08/17/2006CA2598429A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
08/16/2006EP1019075B9 Beta 2-adrenergic receptor agonists
08/16/2006EP0815288B1 Methods of inhibiting corrosion using n-halo-azoles
08/16/2006CN1819998A Optically active halohydrin derivative and process for producing optically active epoxy alcohol derivative from the same
08/16/2006CN1819996A Naphthylene derivatives as cytochrome P450 inhibitors
08/16/2006CN1817883A New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound
08/15/2006US7091380 Bradykinin B1 antagonists or inverse agonists, for prophylaxis and therapy of pain and inflammation
08/10/2006WO2006083271A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/10/2006WO2006055404A3 Compounds for targeting mechanisms implicated in the progression of stroke
08/10/2006WO2006026356A3 S-TRIAZOLYL α-MERCAPTOACETANILDES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE
08/10/2006US20060178415 Azole derivatives as antifungal agents
08/10/2006US20060178345 Substituted alcohols useful in treatment of Alzheimer's disease
08/10/2006CA2566809A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/09/2006EP1687284A2 p-38 KINASE INHIBITORS
08/09/2006EP1401806B1 Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
08/09/2006CN1814597A New method for preparing voriconazole
08/09/2006CN1814596A Muscarinic agonists
08/09/2006CN1268625C Cyclic amp-specific phosphodiesterase inhibitors
08/09/2006CN1268615C Substituted benzoylcyclohexenones
08/09/2006CN1268333C Indolinone compounds for the treatment of disease
08/03/2006WO2006047631A3 Anti-mitotic anti-proliferative compounds
08/03/2006US20060173061 New beta-agonists, processes for preparing them and their use as pharmaceutical compositions
08/03/2006US20060173058 Kcnq channel modulating compounds and their pharmaceutical use
08/03/2006US20060173020 1,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide derivatives
08/03/2006CA2592116A1 Anti-inflammatory medicaments
08/02/2006EP1014966B1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
08/02/2006CN1812717A Triazolopyrimidines
08/02/2006CN1810806A Prepn process and intermediate for voriconazole
08/02/2006CN1267507C Novel fluorinated dye stabilizers in fluorinated dielectric solvent
08/02/2006CN1267430C Triazole compounds with dopamine -D3-receptor affinity
08/01/2006US7084280 Benzotriazol-1-yl-aminoacetonitrile compounds and their use in the control of parasite disease
08/01/2006US7084208 Textile grafted with bactericide
08/01/2006US7084164 Triazole derivative
08/01/2006CA2379903C Novel benzotriazoles anti-inflammatory compounds
08/01/2006CA2189456C Substituted aromatic thiocarboxylic acid amides and their use as herbicides
07/2006
07/27/2006US20060167070 Triazole compounds that modulate Hsp90 activity
07/27/2006US20060167053 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance
07/27/2006US20060166990 Novel aminobenzophenone compounds
07/26/2006EP1682494A1 Aralkyl amines as cannabinoid receptor modulators
07/26/2006EP1681924A1 Biphenyl derivative or its salt, and pesticide containing it as an active ingredient
07/26/2006EP1601672B1 Triazolo-pyridines as anti-inflammatory compounds
07/26/2006EP0655061B2 Method of increasing the spf rating and compounds suitable for increasing the spf rating of fibre or fabric
07/26/2006CN1807419A 1,2,4-triazole [4,3-alpha] chinoline -1-one derivative as antiepileptics medicine and its pharmaceutical salts
07/26/2006CN1266112C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
07/26/2006CN1265790C Anti-fungal remedy formulation for external application
07/20/2006WO2006076702A1 MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ĸB ACTIVITY AND USE THEREOF
07/20/2006WO2006074796A1 Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
07/20/2006US20060160832 Nitrogen-containing aromatic derivatives
07/20/2006US20060160794 Such as [1-(3,5-bis-trifluoromethylbenzyl)-5-imidazol-1-yl-1H-[1,2,3]triazol-4-yl]-[5-(2-chlorophenyl)-3-hydroxymethyl-isoxazol-4-yl]-methanone; for treatment of depression, anxiety, irritable bowel syndrome, and emesis
07/20/2006DE102005000903A1 New 3,4,5-substituted 1,2,4-triazole derivative useful as charge transfer materials for organic light emitting diodes
07/20/2006CA2594384A1 Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
07/19/2006EP1680114A2 Triazole compounds and uses related thereto
07/19/2006CN1805943A Alpha substituted carboxylic acid as PPAR modulators
07/19/2006CN1803780A Triazole compounds and preparing process and use thereof
07/18/2006US7078565 Benzamide derivatives as antagonists of orexin receptors
07/18/2006US7078426 Central nervous system disorders
07/18/2006US7078421 Substituted phenylacetic acids
07/13/2006WO2006004598A3 Proteomic analysis
07/13/2006US20060155136 Optically active halohydrin derivative and process for producing optically active epoxy alcohol derivative from the same
07/13/2006US20060154967 e.g. [2-methyl-5-trifluoromethyl-2H-1,2,3-triazole-4-carboxylic acid methyl ester; fungicide; against the phytopathogenic fungi: Fungi imperfecti (Botrytis, Pyricularia, Helminthosporium), Basidiomycetes (Rhizoctonia, Hemileia), Ascomycetes classes (Venturia, Erysiphe), Oomycetes classes (Phytophthora)
07/13/2006CA2594488A1 Novel heteropyrrole analogs acting on cannabinoid receptors
07/12/2006EP1678180A1 Substituted 2h- 1,2,4 triazolo 4,3-a pyrazines as gsk-3 inhibitors
07/12/2006EP1677786A1 5-substituted 2-(phenylmethyl)thio-4-phenyl-4h-1,2,4-triazole derivatives and related compounds as gaba-agonists for the treatment of urinary incontinence and related diseases
07/12/2006EP1504009B1 Fungicidal triazolopyrimidines, method for the production thereof, use thereof for controlling harmful fungi, and agents containing said fungicidal triazolopyrimidines
07/12/2006CN1802379A Triazolopyrimidines
07/11/2006US7074906 Organic solvent-free process for the preparation of 2-(2-nitrophenylazo)phenols
07/11/2006US7074870 Styrene polymers and phenol-triazole type complexes, catalysts, and processes for polymerizing
07/11/2006US7074867 Ion conducting polymers
07/11/2006US7074816 Gout; xanthine oxidase inhibitors; reacting iminoether or an aromatic nitrile with hydrazide
07/11/2006US7074815 4-[3,5-bis-(2-hydroxy-phenyl)-[1,2,4]triazol-1-yl]-benzoic acid derivatives for treating an excess of metal in the body
07/11/2006US7074810 Triazolone and triazolethione derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme
07/11/2006US7074780 Substituted phenylcyclohexanecarboxamides and their use
1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 178